John J Orloff Alexion Pharmaceuticals, Inc. (ALXN) insider trading activity

John J Orloff is EVP, Research & Development of ALEXION PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ALXN, which is worth approximately $0. The most recent transaction as insider was on Jul 21, 2021, when has been sold 146,511 shares (Common Stock, par value $.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

JOHN J ORLOFF Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 21 2021	SELL Sale (or disposition) back to the issuer	-	146,511 Reduced 100.0%	0 Common Stock, par valu...
Jul 14 2021	BUY Grant, award, or other acquisition	-	60,144 Added 29.1%	146,511 Common Stock, par valu...
Jun 08 2021	SELL Payment of exercise price or tax liability	$346,389 $177.0 p/Share	1,957 Reduced 2.22%	86,367 Common Stock, par valu...
Feb 28 2021	BUY Grant, award, or other acquisition	-	24,473 Added 21.7%	88,324 Common Stock, par valu...
Dec 16 2020	SELL Payment of exercise price or tax liability	$3,379,554 $157.96 p/Share	21,395 Reduced 25.11%	63,811 Common Stock, par valu...
Dec 16 2020	BUY Grant, award, or other acquisition	-	40,677 Added 32.31%	85,206 Common Stock, par valu...
Dec 15 2020	BUY Grant, award, or other acquisition	$3,741 $93.53 p/Share	40 Added 0.06%	63,851 Common Stock, par valu...

Also insider at

ZBIO

Zenas BioPharma, Inc.

Director

JJO

John J Orloff

EVP, Research & Development

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXN shares.

Notify only if

Value

Insider Trading

Get notified when an Alexion Pharmaceuticals, Inc. insider buys or sells ALXN shares.

Notify only if

Operation

Value

Type

News

Receive news related to ALEXION PHARMACEUTICALS, INC.

Track Activities on ALXN

Account